Vaccines Strategic Roundup: Evidence-Driven Competition | Sep 11 – Oct 14, 2026
Vaccine market trends highlight growing competition around clinical evidence…
Vaccine Strategic Roundup I Aug 08 – Sep 10, 2026
Vaccine Strategic Roundup exploring Developments and Competitive Shifts…
Vaccine Strategic Roundup I July 06 – Aug 07, 2026
Vaccine Strategic Roundup exploring Developments and Competitive Shifts…
Intravacc and SynphaBase Conjugate Vaccine Partnership | Lucid Diligence Brief
Can Intravacc and SynphaBase create a streamlined synthetic glycan-to-GMP…
Vaccines Today—June 12, 2026
This weekly update in Vaccines and Immunization highlights key developments…
Why Lower Reactogenicity Alone Will Not Disrupt the Next-Generation Shingles Vaccine Market
Produced with LucidWargames, part of the LucidQuest ecosystem. AI-enabled…
Public Health Today—May 29, 2026
This week’s public health update covers advances in cardiovascular and…
Vaccines Today—May 22, 2026
This weekly update covers recent developments in vaccine research, including…
Vaccines Today—May 15, 2026
This weekly vaccines update covers early-stage clinical progress, immunotherapy…
Healthcare and Pharma Industry Trends H2 2025: From Innovation to Execution
An in-depth analysis of pharma and healthcare industry trends in H2 2025,…
Lucid Diligence Brief: ILiAD Biotechnologies $115 million Series B for pertussis vax
Lucid Diligence Brief: ILiAD Biotechnologies $115 million Series B for…
Lucid Diligence Brief: Sanofi moves to buy Dynavax for $2.2B
Lucid Diligence Brief: Sanofi moves to buy Dynavax for $2.2B Professional…